The most effective GLP-1 medication is now available in a multi-dose pen NEW YORK, April 2, 2026 /PRNewswire/ -- Ro, the leading direct-to-patient healthcare company, today announced that it is working with Eli Lilly to launch the recently FDA-approved Zepbound (tirzepatide) KwikPen nationwide on its platform
A new view of diabetic retinopathy: a neurodegenerative disease of the eye
Many tirzepatide patients in West Virginia notice reduced cravings, increased satiety, and earlier physical results
Patients who actively participate in lifestyle modification programs while on semaglutide tend to achieve and maintain the most significant and lasting weight loss
Cozza A, Chinig C, Filicetti E, Greco GI, Lappano R, Marinaro C, Muglia L, Soraci L, Corsonello A, Lattanzio F, Volpentesta M (2025) Effects of antidiabetic medications on the relationship between type 2 diabetes mellitus and cognitive impairment
Somatostatin Somatostatin, which is a hormone released by islet-delta cells, has been shown to have negative effects on both insulin and glucagon secretion